Axon Therapies
New York, New York, United States
Axon Therapies, Inc. is a healthcare startup focused on transforming heart failure treatment through its innovative Splanchnic Ablation for Volume Management (SAVM) procedure. This minimally invasive, implant-free approach uses the Satera Ablation System to unilaterally ablate the Greater Splanchnic Nerve, aiming to reduce sympathetic nerve activity, normalize volume balance, and improve cardiac functional capacity in heart failure patients with preserved ejection fraction (HFpEF). The procedure has demonstrated positive clinical outcomes, showcasing significant reductions in pulmonary capillary wedge pressure and improvements in quality of life and exercise capacity, making it a promising solution in a field with limited therapeutic options.
Company Info
- Founded
- 2020
- Website
- axontherapies.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Axon Therapies?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.